QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
NYSE:NHI

National Health Investors (NHI) Stock Forecast, Price & News

$51.14
-0.97 (-1.86%)
(As of 09/26/2023 ET)
Compare
Today's Range
$51.10
$51.99
50-Day Range
$49.68
$56.17
52-Week Range
$47.54
$60.17
Volume
133,725 shs
Average Volume
207,003 shs
Market Capitalization
$2.22 billion
P/E Ratio
20.21
Dividend Yield
7.04%
Price Target
$52.75

National Health Investors MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
3.1% Upside
$52.75 Price Target
Short Interest
Healthy
2.11% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-2.59
Upright™ Environmental Score
News Sentiment
0.37mentions of National Health Investors in the last 14 days
Based on 6 Articles This Week
Insider Trading
Acquiring Shares
$51,400 Bought Last Quarter
Proj. Earnings Growth
4.62%
From $4.33 to $4.53 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.28 out of 5 stars

Finance Sector

497th out of 834 stocks

Real Estate Investment Trusts Industry

108th out of 178 stocks


NHI stock logo

About National Health Investors (NYSE:NHI) Stock

Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

NHI Price History

NHI Stock News Headlines

U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
National Health Investors (NYSE:NHI) Lifted to "Buy" at StockNews.com
Q2 2023 National Health Investors Inc Earnings Call
U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
NHI Announces Second Quarter 2023 Results
NHI Announces Third Quarter 2023 Dividend
NHI - National Health Investors, Inc.
NHI Announces $200 Million Term Loan
Q1 2023 National Health Investors Inc Earnings Call
See More Headlines
Receive NHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Health Investors and its competitors with MarketBeat's FREE daily newsletter.

NHI Company Calendar

Last Earnings
5/09/2022
Ex-Dividend for 8/4 Dividend
6/29/2023
Dividend Payable
8/04/2023
Today
9/26/2023
Ex-Dividend for 11/3 Dividend
9/28/2023
Dividend Payable
11/03/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
Specialized REITs
Sector
Finance
CUSIP
63633D10
Employees
25
Year Founded
1991

Price Target and Rating

Average Stock Price Forecast
$52.75
High Stock Price Forecast
$57.00
Low Stock Price Forecast
$50.00
Forecasted Upside/Downside
+2.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$66.40 million
Pretax Margin
35.62%

Debt

Sales & Book Value

Annual Sales
$278.19 million
Cash Flow
$3.42 per share
Book Value
$29.50 per share

Miscellaneous

Free Float
39,846,000
Market Cap
$2.23 billion
Optionable
Optionable
Beta
0.90

Social Links

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. D. Eric Mendelsohn (Age 61)
    Pres, CEO & Director
    Comp: $1.21M
  • Mr. John L. Spaid (Age 63)
    Exec. VP of Fin., CFO & Treasurer
    Comp: $699.15k
  • Mr. Kevin Carlton Pascoe (Age 42)
    Exec. VP & Chief Investment Officer
    Comp: $456.86k
  • Mr. David Louis Travis (Age 48)
    Sr. VP & Chief Accounting Officer
    Comp: $484.15k
  • Ms. Kristin Sallee Gaines (Age 51)
    Sr. VP & Chief Transaction Officer
    Comp: $564.94k
  • Mr. Dana Rolfson Hambly
    Director of Investor Relations
  • Mr. Kimberly Ouimet
    Director of Corp. Compliance & HR
  • Ms. Michelle R. Kelly
    Sr. VP of Investments
  • Susan V. Sidwell
    Corp. Sec.
  • Ms. Colleen Schaller
    Real Estate Transaction Mang.













NHI Stock - Frequently Asked Questions

Should I buy or sell National Health Investors stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NHI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NHI, but not buy additional shares or sell existing shares.
View NHI analyst ratings
or view top-rated stocks.

What is National Health Investors' stock price forecast for 2023?

3 analysts have issued 12-month price targets for National Health Investors' shares. Their NHI share price forecasts range from $50.00 to $57.00. On average, they expect the company's stock price to reach $52.75 in the next twelve months. This suggests a possible upside of 2.8% from the stock's current price.
View analysts price targets for NHI
or view top-rated stocks among Wall Street analysts.

How have NHI shares performed in 2023?

National Health Investors' stock was trading at $52.22 at the beginning of the year. Since then, NHI shares have decreased by 1.8% and is now trading at $51.30.
View the best growth stocks for 2023 here
.

When is National Health Investors' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our NHI earnings forecast
.

How were National Health Investors' earnings last quarter?

National Health Investors, Inc. (NYSE:NHI) released its earnings results on Monday, May, 9th. The real estate investment trust reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.63 by $0.45. The real estate investment trust earned $71.33 million during the quarter, compared to analysts' expectations of $73.06 million. National Health Investors had a trailing twelve-month return on equity of 8.58% and a net margin of 35.99%. The business's revenue was down 11.8% on a year-over-year basis. During the same period last year, the company earned $1.24 EPS.

How often does National Health Investors pay dividends? What is the dividend yield for National Health Investors?

National Health Investors announced a quarterly dividend on Tuesday, August 8th. Investors of record on Friday, September 29th will be given a dividend of $0.90 per share on Friday, November 3rd. This represents a $3.60 dividend on an annualized basis and a yield of 7.02%. The ex-dividend date is Thursday, September 28th.
Read our dividend analysis for NHI
.

Is National Health Investors a good dividend stock?

National Health Investors (NYSE:NHI) pays an annual dividend of $3.60 per share and currently has a dividend yield of 7.01%. NHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 142.29%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, NHI will have a dividend payout ratio of 79.47% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for NHI.

What guidance has National Health Investors issued on next quarter's earnings?

National Health Investors issued an update on its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of $4.31-$4.35 for the period, compared to the consensus estimate of $4.40. The company issued revenue guidance of -.

What other stocks do shareholders of National Health Investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Cisco Systems (CSCO), Annaly Capital Management (NLY), JPMorgan Chase & Co. (JPM), Simon Property Group (SPG), Energy Transfer (ET), QUALCOMM (QCOM) and Broadcom (AVGO).

What is National Health Investors' stock symbol?

National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI."

Who are National Health Investors' major shareholders?

National Health Investors' stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.73%), State Street Corp (4.75%), Principal Financial Group Inc. (3.79%), Geode Capital Management LLC (2.15%), Charles Schwab Investment Management Inc. (1.60%) and Dimensional Fund Advisors LP (1.40%). Insiders that own company stock include James R Jobe, Robert G Adams and Robert T Webb.
View institutional ownership trends
.

How do I buy shares of National Health Investors?

Shares of NHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is National Health Investors' stock price today?

One share of NHI stock can currently be purchased for approximately $51.30.

How much money does National Health Investors make?

National Health Investors (NYSE:NHI) has a market capitalization of $2.23 billion and generates $278.19 million in revenue each year. The real estate investment trust earns $66.40 million in net income (profit) each year or $2.53 on an earnings per share basis.

How can I contact National Health Investors?

National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The official website for the company is www.nhireit.com. The real estate investment trust can be reached via phone at (615) 890-9100, via email at investorrelations@nhireit.com, or via fax at 615-225-3030.

This page (NYSE:NHI) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -